Mind Medicine Mindmed Inc (MNMD)

Dec 19, 2024, 7:00 AM EST - 4 weeks ago

MindMed to Be Added to the Nasdaq Biotechnology Index

Dec 16, 2024, 7:00 AM EST - 4 weeks ago

MindMed Announces First Patient Dosed in Phase 3 Voyage Study of MM120 in Generalized Anxiety Disorder (GAD)

Dec 11, 2024, 7:00 AM EST - 5 weeks ago

MindMed Scientific Presentations at American College of Neuropsychopharmacology (ACNP) 2024 Congress

Dec 5, 2024, 7:00 AM EST - 6 weeks ago

MindMed Awarded Innovation Passport Designation by the United Kingdom (UK) Innovative Licensing and Access Pathway (ILAP) Steering Group for MM120 Orally Disintegrating Tablet (ODT) for Generalized Anxiety Disorder (GAD)

Dec 3, 2024, 7:00 AM EST - 6 weeks ago

MindMed Appoints Javier Muniz, M.D., as Vice President of Research and Development Strategy

Dec 2, 2024, 7:00 AM EST - 6 weeks ago

MindMed Announces New Employee Inducement Grants

Nov 18, 2024, 7:00 AM EST - 2 months ago

MindMed Appoints Gregg Pratt, Ph.D. as Chief Regulatory and Quality Assurance Officer

Nov 13, 2024, 7:00 AM EST - 2 months ago

MindMed to Participate in Upcoming Investor Conferences

Nov 10, 2024, 9:55 AM EST - 2 months ago

Mind Medicine: No News = Good News

Nov 7, 2024, 8:06 PM EST - 2 months ago

Mind Medicine (MindMed) Inc. (MNMD) Q3 2024 Earnings Call Transcript

Nov 7, 2024, 4:01 PM EST - 2 months ago

MindMed Reports Third Quarter 2024 Financial Results and Business Updates

Nov 4, 2024, 4:04 PM EST - 2 months ago

Mind Medicine: Two Pathways Created From One Pipeline Clinical Candidate

Oct 24, 2024, 7:00 AM EDT - 3 months ago

MindMed to Host Conference Call and Webcast to Discuss Third Quarter 2024 Financial Results and Provide Business Update

Sep 4, 2024, 7:00 AM EDT - 4 months ago

MindMed to Participate in September Investor Conferences

Aug 15, 2024, 12:30 PM EDT - 5 months ago

Psychedelic Stocks: Focus On Their Cash

CMPS

Aug 13, 2024, 11:21 AM EDT - 5 months ago

Mind Medicine (MindMed) Inc. (MNMD) Q2 2024 Earnings Call Transcript

Aug 13, 2024, 7:44 AM EDT - 5 months ago

MindMed readying Phase III trials for LSD therapy to treat anxiety

Aug 13, 2024, 7:01 AM EDT - 5 months ago

Pacific Defense Announces US Army CMFF Program Team

MRNS

Aug 13, 2024, 7:00 AM EDT - 5 months ago

MindMed Reports Second Quarter 2024 Financial Results and Business Updates

Aug 12, 2024, 12:47 PM EDT - 5 months ago

FDA Rejection of MDMA Therapy Isn't End of Psychedelic-Drug Candidates

Aug 12, 2024, 12:12 PM EDT - 5 months ago

Psychedelic drug contender stocks drop after FDA rejects MDMA treatment

ATAI CMPS CYBN

Aug 9, 2024, 8:44 AM EDT - 5 months ago

Mind Medicine (MindMed) Inc. Announces Pricing of Public Offering

Aug 9, 2024, 6:00 AM EDT - 5 months ago

Mind Medicine (MindMed) Inc. Announces Proposed Public Offering

Aug 7, 2024, 2:29 PM EDT - 5 months ago

MindMed And Other Psychedelic Stocks Brace For FDA's Decision On MDMA Therapy

Aug 6, 2024, 4:01 PM EDT - 5 months ago

MindMed to Present at Canaccord Genuity's 44th Annual Growth Conference

Aug 6, 2024, 7:00 AM EDT - 5 months ago

MindMed to Host Conference Call and Webcast to Discuss Second Quarter 2024 Financial Results and Provide Business Update

Jul 29, 2024, 7:00 AM EDT - 6 months ago

MindMed Appoints Stephanie Fagan as Chief Corporate Affairs Officer

Jul 17, 2024, 7:00 AM EDT - 6 months ago

MindMed Announces Issuance of New Patent for MM120 Orally Disintegrating Tablet (ODT)

Jun 28, 2024, 7:00 AM EDT - 7 months ago

MindMed to be Included in Russell 2000® and Russell 3000® Indexes

Jun 21, 2024, 7:00 AM EDT - 7 months ago

MindMed to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference

Jun 20, 2024, 7:00 AM EDT - 7 months ago

MindMed Announces Constructive End-of-Phase 2 Meeting with U.S. FDA for MM120 in Generalized Anxiety Disorder (GAD)

Jun 5, 2024, 11:46 AM EDT - 8 months ago

MindMed: Despite MDMA Setback, Still Hope In Light Of Differentiating Factors

May 28, 2024, 7:00 AM EDT - 8 months ago

MindMed to Participate in June Conferences

May 23, 2024, 12:15 PM EDT - 8 months ago

Psychedelics Closer To Commercialization; Compass Far And Away The Leader

CMPS

May 9, 2024, 4:01 PM EDT - 9 months ago

MindMed to Participate at May Investor Conferences

May 9, 2024, 8:00 AM EDT - 9 months ago

New Studies Presented at the International Society for Health Economics and Outcomes Research Meeting (ISPOR 24) Show Growing Burden and Impact of Generalized Anxiety Disorder (GAD) in the US

May 8, 2024, 4:01 PM EDT - 9 months ago

MindMed Reports First Quarter 2024 Financial Results and Business Updates

May 4, 2024, 8:00 AM EDT - 9 months ago

MindMed Presents Phase 2b Study of MM120 for Generalized Anxiety Disorder (GAD) at American Psychiatric Association (APA) Annual Meeting in New York

May 2, 2024, 7:00 AM EDT - 9 months ago

MindMed to Host Conference Call and Webcast to Discuss First Quarter 2024 Financial Results and Provide Business Update

Apr 25, 2024, 7:00 AM EDT - 9 months ago

MindMed to Present at Upcoming May Medical Conferences

Apr 4, 2024, 12:43 PM EDT - 10 months ago

Mind Medicine: GAD Program Success Continues With BTD And Positive Treatment Data

Apr 2, 2024, 7:00 AM EDT - 10 months ago

MindMed to Present at Upcoming April Medical Conferences

Apr 1, 2024, 5:00 PM EDT - 10 months ago

MindMed Announces Voluntary Delisting from Cboe Canada

Mar 11, 2024, 7:00 AM EDT - 11 months ago

MindMed to Participate in the Leerink Partners 2024 Global Biopharma Conference

Mar 8, 2024, 2:46 PM EST - 11 months ago

PLTR, MNMD, ODD: Finding Value in the Market

ODD PLTR

Mar 8, 2024, 7:00 AM EST - 11 months ago

Numinus Wellness Congratulates MindMed on Positive Results from Phase 2B Clinical Trials of MM120 for Generalized Anxiety Disorder

Mar 7, 2024, 7:13 AM EST - 11 months ago

Mind Medicine (MindMed) Inc. Announces Pricing of Underwritten Offering of Common Shares and Concurrent Private Placement

Mar 7, 2024, 6:00 AM EST - 11 months ago

MindMed Receives FDA Breakthrough Therapy Designation and Announces Positive 12-Week Durability Data From Phase 2B Study of MM120 for Generalized Anxiety Disorder

Mar 1, 2024, 9:00 AM EST - 11 months ago

MindMed to Host Conference Call and Webcast to Discuss Data Update for MM120

Feb 28, 2024, 10:58 AM EST - 11 months ago

Mind Medicine (MindMed) Inc. (MNMD) Q4 2023 Earnings Call Transcript